Syndivia is committed to enhancing treatment options for cancer patients with solid tumors by leveraging the distinctive properties of targeted DAR1 antibody-drug conjugates, which offer improved tumor penetration, stability, and efficacy.
| Website | https://www.syndivia.com |
| Revenue | $3 million |
| Employees | 7 (4 on RocketReach) |
| Founded | 2014 |
| Address | 8, Allée Gaspard Monge, Strasbourg, Grand Est 67083, FR |
| Phone | +33 3 67 10 42 20 |
| Fax | +33 3 67 10 42 06 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+11 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Antibody Drug Conjugates, Cancer Treatment, Targeted Therapy, Adc Technology, Oncology, Precision Medicine, Therapeutic Antibodies, Solid Tumors, Drug Development, Immunotherapy, Cancer Research, Biotechnology, Pharmaceutical, Drug Delivery, Clinical Trials, New Drugs, Biopharma, Medical Research |
| Competitors | Microsoft, Google, IBM, H2O.ai, TensorFlow User Group (TFUG), PyTorch, SciPy, PyData London, Keras, NumPy +38 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Syndivia employee's phone or email?
The Syndivia annual revenue was $3 million in 2026.
4 people are employed at Syndivia.
Syndivia is based in Strasbourg, Grand Est.
The NAICS codes for Syndivia are [54, 541714, 5417, 54171, 541].
The SIC codes for Syndivia are [873, 87].